Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Biotechnology: Biological Products (No Diagnostic Substances) industry Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Biotechnology: Biological Products (No Diagnostic Substances) industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: Biological Products (No Diagnostic Substances) industry Largest Companies List by Market Cap as of Jan-05-2024

  1. Coherus Biosciences

    World Rank (Jan-05-2024)
    15,058
    Market Cap (Jan-05-2024)
    0.337 Billion USD
    World Rank (Jul-30-2023)
    13,372
    Market Cap (Jul-30-2023)
    0.453 Billion USD
    World Rank (Dec-25-2022)
    12,373
    Market Cap (Dec-25-2022)
    0.502 Billion USD
    World Rank (Jan-07-2022)
    8,781
    Market Cap (Jan-07-2022)
    1.13 Billion USD
    Annual Revenue in USD
    326 Million USD
    Annual Net Income in USD
    -287 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Coherus BioSciences is a Biotechnology company that develops and commercializes high quality therapeutics for major regulated markets. The company annual revenue is 113.6 million USD, net income was 27.9 million USD and 232 employees as on 2020. The headquarters is in USA.
  2. SOPHiA GENETICS SA

    World Rank (Jan-05-2024)
    15,258
    Market Cap (Jan-05-2024)
    0.326 Billion USD
    World Rank (Jul-30-2023)
    16,911
    Market Cap (Jul-30-2023)
    0.248 Billion USD
    World Rank (Dec-25-2022)
    18,495
    Market Cap (Dec-25-2022)
    0.183 Billion USD
    World Rank (Jan-07-2022)
    10,443
    Market Cap (Jan-07-2022)
    0.83 Billion USD
    Headquarters Country
    Company Profile
    Sophia Genetics SA is a healthcare technology company to diseases such as cancer and inherited disorders where combining genomic and phenotypic information is vital to support discoveries, treatment decisions and drug development efforts. The company annual revenue is 28.4 million USD and total assets are 132.1 million USD as on 2020. The headquarters is in Switzerland.
  3. Poseida Therapeutics Inc.

    World Rank (Jan-05-2024)
    15,594
    Market Cap (Jan-05-2024)
    0.308 Billion USD
    World Rank (Jul-30-2023)
    19,594
    Market Cap (Jul-30-2023)
    0.149 Billion USD
    World Rank (Dec-25-2022)
    13,231
    Market Cap (Dec-25-2022)
    0.441 Billion USD
    World Rank (Jan-07-2022)
    14,871
    Market Cap (Jan-07-2022)
    0.40 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -130 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile
    Poseida Therapeutics is a Clinical Stage Biopharmaceutical company focused on gene engineering platform technologies and better treatments to patients with serious diseases with blood cancers like multiple myeloma, solid tumor cancers like prostate and breast cancer, and rare genetic diseases in the liver. The company estimated annual revenue is currently 32.6 million USD per year. The headquarters is in USA.
  4. Agenus

    World Rank (Jan-05-2024)
    15,849
    Market Cap (Jan-05-2024)
    0.296 Billion USD
    World Rank (Jul-30-2023)
    12,322
    Market Cap (Jul-30-2023)
    0.534 Billion USD
    World Rank (Dec-25-2022)
    10,007
    Market Cap (Dec-25-2022)
    0.747 Billion USD
    World Rank (Jan-07-2022)
    10,874
    Market Cap (Jan-07-2022)
    0.77 Billion USD
    Annual Revenue in USD
    98 Million USD
    Annual Operating Income in USD
    -180 Million USD
    Annual Net Income in USD
    -220 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Agenus is a Biotechnology company discovers, manufactures and develops immuno oncology products company. It portfolio is comprised of checkpoint antibodies, cell therapies, vaccines and adjuvants, representing a combination of synergistic agents to deliver curative patients. The company annual revenue is 84.8 million USD and 294 employees as on 2020. The headquarters is in USA.
  5. Bluebird Bio

    World Rank (Jan-05-2024)
    16,197
    Market Cap (Jan-05-2024)
    0.279 Billion USD
    World Rank (Jul-30-2023)
    13,845
    Market Cap (Jul-30-2023)
    0.420 Billion USD
    World Rank (Dec-25-2022)
    11,315
    Market Cap (Dec-25-2022)
    0.595 Billion USD
    World Rank (Jan-07-2022)
    11,640
    Market Cap (Jan-07-2022)
    0.67 Billion USD
    Annual Revenue in USD
    3 Million USD
    Annual Net Income in USD
    -819 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Bluebird Bio is a Gene Therapy and Pharmaceutical company. It is working toward four potential product approvals by 2022 and a pipeline ready to tackle a range of severe diseases. The company is Powered by multiple labs, in house lentiviral vector manufacturing capabilities and future drug product production and it push to find answers for the people who need them by exploring the cutting edge spectrum of gene therapy. The headquarters is in USA.
  6. Fennec Pharmaceuticals

    World Rank (Jan-05-2024)
    16,238
    Market Cap (Jan-05-2024)
    0.276 Billion USD
    World Rank (Jul-30-2023)
    17,282
    Market Cap (Jul-30-2023)
    0.230 Billion USD
    World Rank (Dec-25-2022)
    16,691
    Market Cap (Dec-25-2022)
    0.257 Billion USD
    World Rank (Jan-07-2022)
    21,682
    Market Cap (Jan-07-2022)
    0.12 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -18 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
  7. Sutro Biopharma

    World Rank (Jan-05-2024)
    16,335
    Market Cap (Jan-05-2024)
    0.271 Billion USD
    World Rank (Jul-30-2023)
    16,413
    Market Cap (Jul-30-2023)
    0.271 Billion USD
    World Rank (Dec-25-2022)
    13,959
    Market Cap (Dec-25-2022)
    0.395 Billion USD
    World Rank (Jan-07-2022)
    13,664
    Market Cap (Jan-07-2022)
    0.48 Billion USD
    Annual Revenue in USD
    61 Million USD
    Annual Net Income in USD
    -105 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Healthcare sector company which develops therapies related to Cancer. Headquarters is in California, USA.
  8. INmune Bio Inc.

    World Rank (Jan-05-2024)
    17,467
    Market Cap (Jan-05-2024)
    0.218 Billion USD
    World Rank (Jul-30-2023)
    19,543
    Market Cap (Jul-30-2023)
    0.151 Billion USD
    World Rank (Dec-25-2022)
    20,432
    Market Cap (Dec-25-2022)
    0.126 Billion USD
    World Rank (Jan-07-2022)
    20,122
    Market Cap (Jan-07-2022)
    0.16 Billion USD
    Annual Revenue in USD
    11 Million USD
    Annual Net Income in USD
    -12 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
  9. Lineage Cell Therapeutics Inc.

    World Rank (Jan-05-2024)
    17,561
    Market Cap (Jan-05-2024)
    0.213 Billion USD
    World Rank (Jul-30-2023)
    17,950
    Market Cap (Jul-30-2023)
    0.204 Billion USD
    World Rank (Dec-25-2022)
    19,121
    Market Cap (Dec-25-2022)
    0.163 Billion USD
    World Rank (Jan-07-2022)
    16,648
    Market Cap (Jan-07-2022)
    0.30 Billion USD
    Headquarters Country
    Company Profile
    Lineage Cell Therapeutics is a Clinical Stage Biotechnology company developing novel cellular therapies to treat unmet medical needs. The company total assets are 107.9 million USD as on 2020. The headquarters is in USA.
  10. Adaptimmune Therapeutics

    World Rank (Jan-05-2024)
    17,897
    Market Cap (Jan-05-2024)
    0.200 Billion USD
    World Rank (Jul-30-2023)
    18,058
    Market Cap (Jul-30-2023)
    0.200 Billion USD
    World Rank (Dec-25-2022)
    17,423
    Market Cap (Dec-25-2022)
    0.223 Billion USD
    World Rank (Jan-07-2022)
    12,831
    Market Cap (Jan-07-2022)
    0.55 Billion USD
    Annual Revenue in USD
    7 Million USD
    Annual Net Income in USD
    -186 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country

Share

Ads